MENU
+Compare
PCVX
Stock ticker: NASDAQ
AS OF
Jun 6, 04:59 PM (EDT)
Price
$36.99
Change
+$2.19 (+6.29%)
Capitalization
4.77B

PCVX Vaxcyte Forecast, Technical & Fundamental Analysis

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases... Show more

PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PCVX with price predictions
Jun 05, 2025

PCVX in upward trend: price rose above 50-day moving average on June 05, 2025

PCVX moved above its 50-day moving average on June 05, 2025 date and that indicates a change from a downward trend to an upward trend. In of 41 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 05, 2025. You may want to consider a long position or call options on PCVX as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where PCVX advanced for three days, in of 287 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 226 cases where PCVX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 65 cases where PCVX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PCVX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.491) is normal, around the industry mean (16.332). P/E Ratio (0.000) is within average values for comparable stocks, (59.787). PCVX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.227). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (263.647).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. PCVX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PCVX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

PCVX is expected to report earnings to rise 13.46% to -117 cents per share on August 12

Vaxcyte PCVX Stock Earnings Reports
Q2'25
Est.
$-1.18
Q1'25
Est.
$-1.04
Q4'24
Beat
by $0.10
Q3'24
Beat
by $0.27
Q2'24
Missed
by $0.12
The last earnings report on May 08 showed earnings per share of -103 cents, meeting the estimate of -103 cents. With 1.58M shares outstanding, the current market capitalization sits at 4.77B.
A.I. Advisor
published General Information

General Information

a company which engages in development of vaccines for infectious diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
825 Industrial Road
Phone
+1 650 837-0111
Employees
254
Web
https://www.vaxcyte.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IGA9.980.01
+0.10%
Voya Global Advantage AND Premium Opportunity Fund
AGIH24.52N/A
N/A
iShares Inflation Hdg U.S. Aggt Bd ETF
EMHY38.08-0.01
-0.03%
iShares J.P. Morgan EM High Yld Bd ETF
QLTA46.84-0.17
-0.36%
iShares Aaa - A Rated Corporate Bond ETF
ADFI8.43-0.04
-0.50%
Anfield Dynamic Fixed Income ETF

PCVX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PCVX has been loosely correlated with ORKA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PCVX jumps, then ORKA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCVX
1D Price
Change %
PCVX100%
+2.84%
ORKA - PCVX
43%
Loosely correlated
+4.62%
DYN - PCVX
41%
Loosely correlated
+4.40%
DNLI - PCVX
40%
Loosely correlated
-1.35%
STOK - PCVX
38%
Loosely correlated
-0.73%
KYMR - PCVX
38%
Loosely correlated
+7.68%
More